aspirin has been researched along with Pneumonia in 49 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Pneumonia: Infection of the lung often accompanied by inflammation.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this study was to test the hypothesis that aspirin would reduce the risk for acute coronary syndromes (ACSs) in patients with pneumonia." | 9.17 | Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial. ( Abakay, O; Akkoyun, CD; Bulut, I; Cetinkaya, E; Elitok, A; Ersin, G; Gibson, MC; Gul, S; Kaya, MG; Oflaz, H; Oncul, A; Oz, F; Yazici, M, 2013) |
" In older patients hospitalized for SARS-CoV-2 pneumonia, we aimed to investigate the association between aspirin use before admission and the risk of in-hospital all-cause mortality." | 8.12 | Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia. ( Bermejo, M; Bouiller, K; Fèvre, A; Gilis, M; Hacquin, A; Hoefler, F; Laborde, C; Manckoundia, P; Mendes, A; Prendki, V; Putot, A; Sanchez, S; Serratrice, C; Sullerot, C, 2022) |
"This study provides supporting evidence that aspirin use is associated with reduced ischaemic events after pneumonia in a primary care setting." | 8.02 | Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database. ( Arnold, D; Hamilton, F; Henley, W; Payne, RA, 2021) |
" Here we assessed the contribution of clopidogrel versus aspirin to the development of pneumonia during an acute ischemic stroke admission." | 8.02 | Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients. ( Feng, Q; Fu, J; Jin, X; Shan, B; Shen, R; Yu, Z; Zhou, H; Zhu, H, 2021) |
"This study evaluated the association between long-term low-dose aspirin use and decreased risk of pneumonia in patients with cardio-cerebra-vascular ischemic diseases (CCVDs)." | 8.02 | Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study. ( Chen, YC; Chen, YY; Chou, MC; Huang, JY; Liao, PL; Yang, SF; Yeh, CB; Yeh, HW; Yeh, LT; Yeh, TY, 2021) |
"This study shows that chronic aspirin use is associated with lower mortality rate within 30 days after hospital admission in a large cohort of patients with pneumonia." | 7.81 | Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. ( Barillà, F; Bertazzoni, G; Calvieri, C; Cangemi, R; Falcone, M; Farcomeni, A; Palange, P; Russo, A; Scarpellini, MG; Taliani, G; Venditti, M; Violi, F, 2015) |
"This article examines retrospectively the possibility of using aspirin and statins to prevent exacerbation and infection in patients with COPD." | 7.81 | No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease. ( Yayan, J, 2015) |
" Aspirin non-responsiveness is more frequent in severe infections, such as pneumonia." | 7.74 | Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection. ( Karlsson, F; Modica, A; Mooe, T, 2007) |
"Aspirin-intolerant asthma (AIA), a major clinical presentation of aspirin hypersensitivity, affects 10% of adult asthmatics." | 7.74 | Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics. ( Cho, BY; Jeong, HH; Kim, M; Kim, SH; Lee, HY; Lee, J; Park, HS; Wee, K, 2008) |
"Systematic inflammation has been reported to contribute to cancer progression through various mechanisms; however, the exact mechanism is still the subject of research." | 5.91 | Inhibitory effect of aspirin on inflammation-induced lung metastasis of cancer cells associated with neutrophil infiltration. ( Fukuda, K; Hirahashi, J; Kawakubo, H; Kitagawa, Y; Kobayashi, R; Matsuda, S; Matsui, K; Nakamura, R; Nishimura, E; Okubo, K; Takeuchi, M, 2023) |
"Ticlopidine is an antiplatelet agent that has been proven efficacious in preventing vascular events in patients with a history of vasculopathy." | 5.30 | Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative. ( Armstrong, PW; Brown, NE; Gill, S; Majumdar, S, 1997) |
"MI is an early complication of pneumonia and is associated with in vivo platelet activation and serum TxB2 overproduction; aspirin 100 mg/day seems insufficient to inhibit thromboxane biosynthesis." | 5.19 | Platelet activation is associated with myocardial infarction in patients with pneumonia. ( Bertazzoni, G; Bucci, T; Calabrese, CM; Calvieri, C; Cangemi, R; Casciaro, M; Falcone, M; Farcomeni, A; Grieco, S; Palange, P; Pignatelli, P; Rossi, E; Taliani, G; Violi, F, 2014) |
"The aim of this study was to test the hypothesis that aspirin would reduce the risk for acute coronary syndromes (ACSs) in patients with pneumonia." | 5.17 | Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial. ( Abakay, O; Akkoyun, CD; Bulut, I; Cetinkaya, E; Elitok, A; Ersin, G; Gibson, MC; Gul, S; Kaya, MG; Oflaz, H; Oncul, A; Oz, F; Yazici, M, 2013) |
" In older patients hospitalized for SARS-CoV-2 pneumonia, we aimed to investigate the association between aspirin use before admission and the risk of in-hospital all-cause mortality." | 4.12 | Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia. ( Bermejo, M; Bouiller, K; Fèvre, A; Gilis, M; Hacquin, A; Hoefler, F; Laborde, C; Manckoundia, P; Mendes, A; Prendki, V; Putot, A; Sanchez, S; Serratrice, C; Sullerot, C, 2022) |
"This study provides supporting evidence that aspirin use is associated with reduced ischaemic events after pneumonia in a primary care setting." | 4.02 | Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database. ( Arnold, D; Hamilton, F; Henley, W; Payne, RA, 2021) |
" Here we assessed the contribution of clopidogrel versus aspirin to the development of pneumonia during an acute ischemic stroke admission." | 4.02 | Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients. ( Feng, Q; Fu, J; Jin, X; Shan, B; Shen, R; Yu, Z; Zhou, H; Zhu, H, 2021) |
"This study evaluated the association between long-term low-dose aspirin use and decreased risk of pneumonia in patients with cardio-cerebra-vascular ischemic diseases (CCVDs)." | 4.02 | Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study. ( Chen, YC; Chen, YY; Chou, MC; Huang, JY; Liao, PL; Yang, SF; Yeh, CB; Yeh, HW; Yeh, LT; Yeh, TY, 2021) |
"This study shows that chronic aspirin use is associated with lower mortality rate within 30 days after hospital admission in a large cohort of patients with pneumonia." | 3.81 | Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. ( Barillà, F; Bertazzoni, G; Calvieri, C; Cangemi, R; Falcone, M; Farcomeni, A; Palange, P; Russo, A; Scarpellini, MG; Taliani, G; Venditti, M; Violi, F, 2015) |
"This article examines retrospectively the possibility of using aspirin and statins to prevent exacerbation and infection in patients with COPD." | 3.81 | No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease. ( Yayan, J, 2015) |
" Aspirin non-responsiveness is more frequent in severe infections, such as pneumonia." | 3.74 | Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection. ( Karlsson, F; Modica, A; Mooe, T, 2007) |
"Aspirin-intolerant asthma (AIA), a major clinical presentation of aspirin hypersensitivity, affects 10% of adult asthmatics." | 3.74 | Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics. ( Cho, BY; Jeong, HH; Kim, M; Kim, SH; Lee, HY; Lee, J; Park, HS; Wee, K, 2008) |
" There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
"Systematic inflammation has been reported to contribute to cancer progression through various mechanisms; however, the exact mechanism is still the subject of research." | 1.91 | Inhibitory effect of aspirin on inflammation-induced lung metastasis of cancer cells associated with neutrophil infiltration. ( Fukuda, K; Hirahashi, J; Kawakubo, H; Kitagawa, Y; Kobayashi, R; Matsuda, S; Matsui, K; Nakamura, R; Nishimura, E; Okubo, K; Takeuchi, M, 2023) |
"Aspirin was administered to 40% and BBs to 17% of patients with AMI." | 1.34 | National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia. ( Kelen, GD; Pham, JC; Pronovost, PJ, 2007) |
"Ticlopidine is an antiplatelet agent that has been proven efficacious in preventing vascular events in patients with a history of vasculopathy." | 1.30 | Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative. ( Armstrong, PW; Brown, NE; Gill, S; Majumdar, S, 1997) |
" The 5-lipoxygenase inhibitor diethylcarbamazine and the LTD4/LTE4 receptor antagonist LY 171883 markedly reduced mortality in dose-response fashion." | 1.28 | Effects of some nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. ( Gross, NJ; Holloway, NO; Narine, KR, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (34.69) | 18.7374 |
1990's | 2 (4.08) | 18.2507 |
2000's | 9 (18.37) | 29.6817 |
2010's | 12 (24.49) | 24.3611 |
2020's | 9 (18.37) | 2.80 |
Authors | Studies |
---|---|
Sullerot, C | 1 |
Bouiller, K | 1 |
Laborde, C | 1 |
Gilis, M | 1 |
Fèvre, A | 1 |
Hacquin, A | 1 |
Manckoundia, P | 1 |
Hoefler, F | 1 |
Bermejo, M | 1 |
Mendes, A | 1 |
Serratrice, C | 1 |
Prendki, V | 1 |
Sanchez, S | 1 |
Putot, A | 1 |
Nishimura, E | 1 |
Fukuda, K | 1 |
Matsuda, S | 1 |
Kobayashi, R | 1 |
Matsui, K | 1 |
Takeuchi, M | 1 |
Okubo, K | 1 |
Hirahashi, J | 1 |
Nakamura, R | 1 |
Kawakubo, H | 1 |
Kitagawa, Y | 1 |
Hamilton, F | 1 |
Arnold, D | 1 |
Henley, W | 1 |
Payne, RA | 1 |
Yu, Z | 1 |
Zhou, H | 1 |
Shan, B | 1 |
Fu, J | 1 |
Zhu, H | 1 |
Feng, Q | 1 |
Shen, R | 1 |
Jin, X | 1 |
Bhat, TA | 1 |
Kalathil, SG | 1 |
Miller, A | 1 |
Thatcher, TH | 1 |
Sime, PJ | 1 |
Thanavala, Y | 1 |
Giorgi-Pierfranceschi, M | 1 |
Kolditz, M | 1 |
Welte, T | 1 |
Karruli, A | 1 |
Boccia, F | 1 |
Gagliardi, M | 1 |
Patauner, F | 1 |
Ursi, MP | 1 |
Sommese, P | 1 |
De Rosa, R | 1 |
Murino, P | 1 |
Ruocco, G | 1 |
Corcione, A | 1 |
Andini, R | 1 |
Zampino, R | 1 |
Durante-Mangoni, E | 1 |
Chen, YC | 1 |
Chen, YY | 1 |
Yeh, HW | 1 |
Yeh, TY | 1 |
Huang, JY | 1 |
Liao, PL | 1 |
Yeh, LT | 1 |
Yang, SF | 1 |
Chou, MC | 1 |
Yeh, CB | 1 |
Whitmore, TJ | 1 |
O'Shea, JP | 1 |
Starac, D | 1 |
Edwards, MG | 1 |
Waterer, GW | 1 |
Tang, H | 1 |
Liu, Y | 1 |
Yan, C | 1 |
Petasis, NA | 1 |
Serhan, CN | 1 |
Gao, H | 1 |
Cangemi, R | 2 |
Casciaro, M | 1 |
Rossi, E | 1 |
Calvieri, C | 2 |
Bucci, T | 1 |
Calabrese, CM | 1 |
Taliani, G | 2 |
Falcone, M | 3 |
Palange, P | 2 |
Bertazzoni, G | 2 |
Farcomeni, A | 3 |
Grieco, S | 1 |
Pignatelli, P | 1 |
Violi, F | 3 |
Russo, A | 2 |
Barillà, F | 1 |
Scarpellini, MG | 1 |
Venditti, M | 2 |
Yayan, J | 1 |
Pieralli, F | 1 |
Vannucchi, V | 1 |
Vullo, V | 1 |
Otoshi, T | 1 |
Kataoka, Y | 1 |
Nakagawa, A | 1 |
Otsuka, K | 1 |
Tomii, K | 1 |
Castro, P | 1 |
Nasser, H | 1 |
Abrahão, A | 1 |
Dos Reis, LC | 1 |
Riça, I | 1 |
Valença, SS | 1 |
Rezende, DC | 1 |
Quintas, LE | 1 |
Cavalcante, MC | 1 |
Porto, LC | 1 |
Koatz, VL | 1 |
Wu, YZ | 1 |
Abolhassani, M | 1 |
Ollero, M | 1 |
Dif, F | 1 |
Uozumi, N | 1 |
Lagranderie, M | 1 |
Shimizu, T | 1 |
Chignard, M | 1 |
Touqui, L | 1 |
Werner, RM | 1 |
Bradlow, ET | 1 |
Asch, DA | 1 |
Jonville-Béra, AP | 1 |
Bejan-Angoulvant, T | 1 |
Oz, F | 1 |
Gul, S | 1 |
Kaya, MG | 1 |
Yazici, M | 1 |
Bulut, I | 1 |
Elitok, A | 1 |
Ersin, G | 1 |
Abakay, O | 1 |
Akkoyun, CD | 1 |
Oncul, A | 1 |
Cetinkaya, E | 1 |
Gibson, MC | 1 |
Oflaz, H | 1 |
Moon, HG | 1 |
Kang, CS | 1 |
Choi, JP | 1 |
Choi, DS | 1 |
Choi, HI | 1 |
Choi, YW | 1 |
Jeon, SG | 1 |
Yoo, JY | 1 |
Jang, MH | 1 |
Gho, YS | 1 |
Kim, YK | 1 |
Martinussen, T | 1 |
Vansteelandt, S | 1 |
PETERSDORF, RG | 1 |
CLUFF, LE | 1 |
HOEPRICH, PD | 1 |
HOPKINS, FT | 1 |
MCCANN, WP | 1 |
HONMA, M | 1 |
MICHIGAWA, K | 1 |
KIMURA, T | 1 |
NAGANO, S | 1 |
SHIMADA, H | 1 |
PHELAN, PD | 1 |
MELI, A | 1 |
SMITH, CR | 1 |
WOLFF, A | 1 |
HERRMANN, EC | 1 |
ENGLE, C | 1 |
PERLMAN, PL | 1 |
IVERSEN, T | 1 |
SCHIØDT, E | 1 |
Modica, A | 1 |
Karlsson, F | 1 |
Mooe, T | 1 |
Jha, AK | 1 |
Orav, EJ | 1 |
Li, Z | 1 |
Epstein, AM | 1 |
Pham, JC | 1 |
Kelen, GD | 1 |
Pronovost, PJ | 1 |
Kim, SH | 1 |
Jeong, HH | 1 |
Cho, BY | 1 |
Kim, M | 1 |
Lee, HY | 1 |
Lee, J | 1 |
Wee, K | 1 |
Park, HS | 1 |
Vizioli, A | 1 |
Zamperini, D | 1 |
Ursaia, G | 1 |
Gill, S | 1 |
Majumdar, S | 1 |
Brown, NE | 1 |
Armstrong, PW | 1 |
Forman, HJ | 1 |
Yoo, CG | 1 |
Lee, S | 1 |
Lee, CT | 1 |
Kim, YW | 1 |
Han, SK | 1 |
Shim, YS | 1 |
Bauer, AK | 1 |
Dwyer-Nield, LD | 1 |
Hankin, JA | 1 |
Murphy, RC | 1 |
Malkinson, AM | 1 |
Douglas, RG | 1 |
Gross, NJ | 1 |
Holloway, NO | 1 |
Narine, KR | 1 |
Sheleg, VA | 2 |
Maier, WP | 1 |
Leon-Perez, R | 1 |
Miller, SB | 1 |
Protsenko, GN | 1 |
Makarevich, OV | 1 |
Kallee, E | 1 |
Miller, GC | 1 |
Witham, AC | 1 |
Van Reken, D | 1 |
Strauss, A | 1 |
Hernandez, A | 1 |
Feigin, RD | 1 |
Scherz, RG | 1 |
Harrison, JF | 1 |
Parker, RW | 1 |
De Silva, KL | 1 |
Currier, RD | 1 |
Haerer, AF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Retrospective Single-center Cohort Study to Evaluate the Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19 Admitted to a Large Intensive Care Unit in Milan, Italy[NCT05293418] | 435 participants (Actual) | Observational | 2020-10-01 | Completed | |||
Effect of Corticosteroids On MyocardiaL Injury Among Patients Hospitalized for Community-AcquirEd PneUMonia - COLOSSEUM TRIAL[NCT03745664] | Phase 3 | 122 participants (Anticipated) | Interventional | 2021-01-10 | Recruiting | ||
Major Adverse Cardiac and Cerebrovascular Events in Hospitalized Patients With Community-acquired Pneumonia[NCT01773863] | 500 participants (Anticipated) | Observational | 2011-10-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for aspirin and Pneumonia
Article | Year |
---|---|
Platelet activation is associated with myocardial infarction in patients with pneumonia.
Topics: Aged; Aspirin; Biomarkers; CD40 Ligand; Community-Acquired Infections; Electrocardiography; Female; | 2014 |
Platelet activation is associated with myocardial infarction in patients with pneumonia.
Topics: Aged; Aspirin; Biomarkers; CD40 Ligand; Community-Acquired Infections; Electrocardiography; Female; | 2014 |
Platelet activation is associated with myocardial infarction in patients with pneumonia.
Topics: Aged; Aspirin; Biomarkers; CD40 Ligand; Community-Acquired Infections; Electrocardiography; Female; | 2014 |
Platelet activation is associated with myocardial infarction in patients with pneumonia.
Topics: Aged; Aspirin; Biomarkers; CD40 Ligand; Community-Acquired Infections; Electrocardiography; Female; | 2014 |
Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Biomarkers; Cardiovascular Agents; Chi-Square Distribution; | 2013 |
[Clinical trial of guacetisal in aged subjects with inflammatory diseases of the respiratory tract].
Topics: Aged; Anti-Inflammatory Agents; Aspirin; Bronchitis; Clinical Trials as Topic; Common Cold; Female; | 1982 |
46 other studies available for aspirin and Pneumonia
Article | Year |
---|---|
Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; COVID-19; Humans; Inpatients; Pneumonia; Retrospec | 2022 |
Inhibitory effect of aspirin on inflammation-induced lung metastasis of cancer cells associated with neutrophil infiltration.
Topics: Acute Lung Injury; Animals; Aspirin; Humans; Inflammation; Lung; Lung Neoplasms; Mice; Neutrophil In | 2023 |
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database.
Topics: Aged; Aspirin; Brain Ischemia; Humans; Platelet Aggregation Inhibitors; Pneumonia; Primary Health Ca | 2021 |
Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; | 2021 |
Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke.
Topics: Animals; Antibodies; Aspirin; Asthma; B-Lymphocytes; Bronchoalveolar Lavage Fluid; Cytokines; Docosa | 2020 |
Is Aspirin Effective in Preventing Intensive Care Unit Admission in Patients With Coronavirus Disease 2019 Pneumonia?
Topics: Aspirin; COVID-19; Hospital Mortality; Humans; Intensive Care Units; Pneumonia; Respiration, Artific | 2021 |
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go.
Topics: Aspirin; Cardiovascular Diseases; Humans; Platelet Aggregation Inhibitors; Pneumonia | 2021 |
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carb | 2021 |
Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study.
Topics: Aspirin; Cohort Studies; Humans; Pneumonia; Retrospective Studies; Risk Factors | 2021 |
A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Biopsy; Coronary Artery Bypass; Diagnosis, Differential | 2014 |
Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Antibody Complex; Aspir | 2014 |
Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Community-Acquired Infections; Confidence In | 2015 |
No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease.
Topics: Aged; Aspirin; C-Reactive Protein; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I | 2015 |
Septic shock from community-onset pneumonia: is there a role for aspirin plus macrolides combination?
Topics: Anti-Bacterial Agents; Aspirin; Community-Acquired Infections; Drug Combinations; Humans; Macrolides | 2016 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female | 2016 |
Aspirin and indomethacin reduce lung inflammation of mice exposed to cigarette smoke.
Topics: Animals; Aspirin; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Indomethacin; Male | 2009 |
Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice.
Topics: Administration, Intranasal; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Bronchoalveolar L | 2010 |
Does hospital performance on process measures directly measure high quality care or is it a marker of unmeasured care?
Topics: Anti-Bacterial Agents; Aspirin; Benchmarking; Cardiovascular Agents; Heart Failure; Hospital Adminis | 2008 |
[Drugs news].
Topics: 4-Hydroxycoumarins; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroida | 2013 |
Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback.
Topics: Animals; Aspirin; Cell Polarity; Feedback, Physiological; Interferon-gamma; Interleukin-17; Interleu | 2013 |
On collapsibility and confounding bias in Cox and Aalen regression models.
Topics: Adult; Aged; Aspirin; Bias; Biostatistics; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; L | 2013 |
Pneumoccocal pneumonia treated with penicillin and aspirin.
Topics: Aspirin; Penicillins; Pneumonia; Pneumonia, Pneumococcal | 1957 |
[Case of rheumatic pneumonia].
Topics: Aspirin; Humans; Penicillin V; Pneumonia; Prednisolone; Rheumatic Fever | 1963 |
ACCIDENTAL POISONING IN CHILDHOOD.
Topics: Accidents; Aspirin; Australia; Barbiturates; Cathartics; Child; Histamine H1 Antagonists; Humans; Hy | 1963 |
ANTI-INFLAMMATORY ASSAY. AN IMPROVED METHOD BASED ON THE REVERSAL OF ENDOTOXIN-INDUCED LUNG INFLAMMATION IN MICE.
Topics: Aerosols; Anti-Inflammatory Agents; Aspirin; Cortisone; Endotoxins; Equipment and Supplies; Mice; Pa | 1964 |
Action of antiinflammatory agents on endotoxin-induced lung inflammation in mice.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Aspirin; Cortisone; Endotoxins; Lung Dis | 1959 |
[Toxicity in therapeutic use of acetylsalicylic acid in infants and children with colds or pneumonia].
Topics: Aspirin; Child; Humans; Infant; Pneumonia | 1951 |
Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection.
Topics: Acute Disease; Aged; Aged, 80 and over; Aspirin; Biomarkers; C-Reactive Protein; Drug Resistance; Fe | 2007 |
Concentration and quality of hospitals that care for elderly black patients.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; | 2007 |
National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Aspir | 2007 |
Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics.
Topics: Adult; Aspirin; Asthma; Female; Genetic Predisposition to Disease; Humans; Korea; Male; Pneumonia; P | 2008 |
Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.
Topics: Aspirin; Cardiovascular Diseases; Drug Resistance; Fatal Outcome; Female; Humans; Middle Aged; Neutr | 1997 |
Another reason for taking aspirin.
Topics: Aspirin; Cells, Cultured; Cyclooxygenase Inhibitors; Humans; Pneumonia; Respiratory Mucosa | 2001 |
Effect of acetylsalicylic acid on endogenous I kappa B kinase activity in lung epithelial cells.
Topics: Aspirin; Bronchi; Cells, Cultured; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Humans; I-kappa | 2001 |
The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspiri | 2001 |
Influenza: the disease and its complications.
Topics: Amantadine; Aspirin; Bacterial Infections; Bronchitis; Central Nervous System Diseases; Cross Infect | 1976 |
Effects of some nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diethylcarbamazine; Ibupro | 1991 |
[Use of fibrinolysis activators and inhibitors in the complex treatment of patients with acute pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifibrinolytic Agents; Aspirin; Drug Therapy, Combination; | 1986 |
Pneumonitis during low-dose methotrexate therapy.
Topics: Arthritis, Rheumatoid; Aspirin; Drug Interactions; Humans; Methotrexate; Pneumonia | 1986 |
[Effectiveness of nicotinic and acetylsalicylic acids in the complex treatment of acute pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Male; Middle A | 1985 |
[Therapy of thyroid crises].
Topics: Aspirin; Ergoloid Mesylates; Fever; Fructose; Humans; Iodine; Magnesium; Meperidine; Methimazole; Ph | 1974 |
Delayed febrile pleuropericarditis after sepsis. A possible analogue of the postcardiotomy syndrome.
Topics: Adult; Aspirin; Blood Sedimentation; Cardiomegaly; Erythrocytes; Female; Fever; Heart Auscultation; | 1973 |
Infectious pericarditis in children.
Topics: Adenoviridae Infections; Adolescent; Ampicillin; Aortic Aneurysm; Aspirin; Bacterial Infections; Chi | 1974 |
The management of accidental childhood poisoning.
Topics: Accidents, Home; Aspirin; Charcoal; Child; Child, Preschool; Humans; Hydrocarbons; Infant; Methadone | 1974 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |
Acute cerebral infarction. Evaluation and treatment.
Topics: Angiography; Anticoagulants; Aspirin; Blood Pressure Determination; Cerebrospinal Fluid; Cerebrovasc | 1973 |